Taken together, our results suggest that B4GALT1 is significantly downregulated in HCC tissue compared with its adjacent non-tumor tissue and that low B4GALT1 expression is associated with poor overall survival of patients with HCC. This evidence concerns the gene B4GALT1 and hepatocellular carcinoma.